| Literature DB >> 35239907 |
Cláudio Queniti Hirai1, Deborah de Castro Moreira1, Danielle Cristina Tita Granzotto2, Eniuce Menezes de Souza2, Jorge Juarez Vieira Teixeira3, Dennis Armando Bertolini3.
Abstract
BACKGROUND: Many human immunodeficiency virus (HIV) and syphilis co-infected patients are not diagnosed, which may evolve into asymptomatic neurosyphilis (ANS). We studied the occurrence of ANS an HIV-infected population.Entities:
Mesh:
Year: 2022 PMID: 35239907 PMCID: PMC8909440 DOI: 10.1590/0037-8682-0418-2021
Source DB: PubMed Journal: Rev Soc Bras Med Trop ISSN: 0037-8682 Impact factor: 1.581
FIGURE 1:Patient selection flowchart. VDRL: Veneral Disease Research Laboratory; HIV: human immunodeficiency virus; CSF: cerebrospinal fluid.
Clinical-laboratorial characteristics of the 19 patients with HIV/syphilis co-infection, in Cornélio Procópio, State of Paraná, between 10/01/2018 and 09/30/2019.
| Variables | Patients | P-value | |
|---|---|---|---|
| n | % | ||
|
| 0.490* | ||
| < 5 years | 9 | 47.4 | |
| ≥ 5 years | 10 | 52.6 | |
|
| <0.001 | ||
| Yes | 18 | 94.7 | |
| No | 1 | 5.3 | |
|
| 0.196* | ||
| ≥ 40 | 4 | 21.1 | |
| < LD | 15 | 79.9 | |
|
| 0.251* | ||
| < 350 | 5 | 26.3 | |
| ≥ 350 | 14 | 73.7 | |
|
| <0.001 | ||
| <1:32 | 17 | 89.5 | |
| ≥ 1:32 | 2 | 10.5 | |
|
| <0.001 | ||
| NR | 18 | 94.7 | |
| R | 1 | 5.3 | |
|
| <0.001 | ||
| < 20 | 17 | 89.5 | |
| ≥ 20 | 2 | 10.5 | |
|
| 0.346* | ||
| < 40 | 12 | 63.2 | |
| ≥ 40 | 7 | 36.8 | |
*Not significant, at a 5% level of significance. ART: antiretroviral therapy; CD4LT: CD4+ T lymphocytes; VDRL: Veneral Disease Research Laboratory; CSF: cerebrospinal fluid; ND: not detectable; LD: lower than the minimum detection limit; NR: not reagent; R: reagent.
Distribution of the neurosyphilis among the 19 patients with HIV/syphilis co-infection, Cornélio Procópio, State of Paraná, between 10/01/2018 and 09/30/2019.
| Neurosyphilis | |||
|---|---|---|---|
| No | Yes | Total(%) | |
| Characteristics | n(%) | n(%) | |
|
| |||
| Married/Cohabiting |
|
| 9(47) |
| Other |
|
| 10(53) |
| Total | 11(58) | 8(42) | 19(100) |
|
| |||
| Heterosexual |
|
| 9(47) |
| Other |
|
| 10(53) |
| Total | 11(58) | 8(42) | 19(100) |
|
| |||
| <21 |
|
| 8(42) |
| >21 |
|
| 11(58) |
| Total | 11(58) | 8(42) | 19(100) |
|
| |||
| Non-users |
|
| 8(42) |
| Users |
|
| 11(58) |
| Total | 11(58) | 8(42) | 19(100) |
|
| |||
| Non-users |
|
| 16(84) |
| Users |
|
| 3(16) |
| Total | 11(58) | 8(42) | 19(100) |
|
| |||
| Inadequate, or without history of previous treatment |
|
| 16(84) |
| Adequate |
|
| 3(16) |
|
|
|
|
|
n: number of patients.